This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to .beta.-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.

 
Web www.patentalert.com

< Early Treatment and Prevention of Increased Muscle Tonicity

< PROCESS FOR PREPARING QUINAZOLINE RHO-KINASE INHIBITORS AND INTERMEDIATES THEREOF

> SURGICAL METHOD FOR GASTROCNEMIUS MUSCLE REDUCTION

> METHOD AND APPARATUS FOR REDUCING RENAL BLOOD PRESSURE
~ 00609